Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.

Pigment cell & melanoma research - 1 Aug 2009

Sondak Vernon K, Smalley Keiran

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Antineoplastic Agents
Clinical Trials, Phase III as Topic
KIT gene
Melanoma
Mutation
Neoplasm Metastasis
Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Proto-Oncogene Proteins c-kit

Source

Identifiers

PMID: 19624312
DOI: 10.1111/j.1755-148X.2009.00593.x

Genes

BRAF
KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report.PMID 19624312Read ↗

Biology and Treatment of BRAF Mutant Metastatic MelanomaSemantic proximity Read ↗

Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.Semantic proximity Read ↗

Targeting mutant BRAF in melanoma: current status and future development of combination therapy strategies.Semantic proximity Read ↗

Principles of Targeted Therapy for Melanoma.Semantic proximity Read ↗

Targeted therapies in melanoma beyond BRAF: targeting NRAS-mutated and KIT-mutated melanoma.Semantic proximity Read ↗

BRAF Targeting Across Solid Tumors: Molecular Aspects and Clinical ApplicationsSemantic proximity Read ↗

Targeting activated KIT signaling for melanoma therapy.Semantic proximity Read ↗

BRAF as a potential therapeutic target in melanoma and other malignancies.Semantic proximity Read ↗

BRAF signaling and targeted therapies in melanoma.Semantic proximity Read ↗

BRAF-MEK inhibition in melanoma brain metastases: a new hope.Semantic proximity Read ↗

Targeting BRAF for patients with melanoma.Semantic proximity Read ↗

BRAF in melanoma: current strategies and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.